MARY ANN MCDONNELL

Nursing Service Providers|Registered Nurse|Psychiatric/Mental Health, Child & Adolescent QUINCY, MA NPI 1285871087

General Payments — all program years on this page

$2,719.05

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 37
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $626.23 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $614.0818
Education $12.151

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $76.902
2022 $1,653.763
2023 $362.1613
2024 $626.2319

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078040608 Janssen Pharmaceuticals, Inc $20.44 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107627675 ABBVIE INC. $29.53 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107627677 ABBVIE INC. $24.59 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107627679 ABBVIE INC. $18.37 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107627681 ABBVIE INC. $19.90 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119134192 Otsuka America Pharmaceutical, Inc. $91.57 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137789933 Takeda Pharmaceuticals U.S.A., Inc. $32.01 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137789935 Takeda Pharmaceuticals U.S.A., Inc. $22.74 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137789937 Takeda Pharmaceuticals U.S.A., Inc. $21.94 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143545098 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $29.89 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143545100 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $119.51 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143545102 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.73 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143545104 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $28.43 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143545106 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.15 06/17/2024 Education Undisputed 01/23/2026 View at CMS
1143545108 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $28.23 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146058792 Lundbeck LLC $29.15 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146058794 Lundbeck LLC $29.25 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148390004 Axsome Therapeutics, Inc. $27.02 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148390006 Axsome Therapeutics, Inc. $13.78 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.